Clinical Trials Logo

Filter by:
NCT ID: NCT01741428 Completed - Clinical trials for Cardiovascular Disease

"Hjerteloeftet" ("HeartLift"). Interaction For Preventing Cardiovascular Disease

HeartLift
Start date: November 2012
Phase: N/A
Study type: Interventional

Early interventions to promote physical activity, dietary lifestyle changes and optimal medication for cardiovascular risk factor reduction - 3 years follow-up. A randomized Clinical Trial.

NCT ID: NCT01741389 Completed - Clinical trials for Spinal Cord Injured, Tetraplegia

The Role of Melatonin in the Regulation of Blood Coagulation

COME
Start date: December 2012
Phase: Phase 1
Study type: Interventional

The main aim is to examine the influence of daylight and melatonin on the temporal variations of hemostatic factors with key roles in the hemostatic process and its regulation. Particular emphasis will be on exploring the role of melatonin in hemostasis by comparing subjects with tetraplegia with able-bodied control subjects.

NCT ID: NCT01740141 Completed - Pain Clinical Trials

Plexus Brachialis Block. Better to do by Start Than by End of Surgery?

Start date: November 2012
Phase: N/A
Study type: Interventional

The aim of the study is to find out if the timing of brachial plexus block, before or after surgery, has an impact of the extent of acute postoperative surgical pain or the incidence and severity of long-lasting (chronic) pain after surgery. This is a prospective, randomized, double blind study in patients with radial fractures undergoing surgery with volar plate. The patients will be followed up for 6 months after surgery.

NCT ID: NCT01740102 Completed - Atrial Fibrillation Clinical Trials

Clinical Value of Remote Ischemic Preconditioning

Start date: August 2012
Phase: N/A
Study type: Interventional

Objectives: Despite utilization of available means for cardioprotection during cardiac surgery, myocardial injury still occurs. Further improvement of cardioprotection is therefore necessary. Remote ischemic preconditioning (RIPC) is an easy and non-invasive method. Laboratory research has shown promising results regarding myocardial survival during open heart surgery, but the clinical value of RIPC is still largely unknown. The investigators hypothesize that RIPC before coronary artery bypass grafting (CABG) reduces the incidence of postoperative atrial fibrillation (POAF).

NCT ID: NCT01738776 Completed - Hip Fracture Clinical Trials

Nutritional Risk Factors for Hip Fracture: a Case Control Study

Start date: September 2009
Phase: N/A
Study type: Observational

Low Body Mass Index (BMI) is a risk factor for hip fracture, but it is unknown if it is the low BMI per se that increases risk of hip fracture or if specific micro-nutrients contribute. The investigators want to elucidate this aspect in a case control study studying micronutrients in serum and bone turnover markers of hip fracture patients compared with controls of the same age.

NCT ID: NCT01737060 Completed - Clinical trials for Proximal Humeral Fractures, AO/OTA (2007) Group B2 and C2

Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate?

DELPHI
Start date: January 1, 2013
Phase: N/A
Study type: Interventional

To investigate the assumption that reversed shoulder prosthetic replacement will give a better functional outcome compared to open reduction and internal fixation with an angular stable plate in displaced proximal humeral fractures. Short name: The DelPhi trial.

NCT ID: NCT01734928 Completed - Multiple Myeloma Clinical Trials

Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

OPTIMISMM
Start date: January 7, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of the combination of pomalidomide, bortezomib and low dose dexamethasone to the combination of bortezomib and low dose dexamethasone in participants with relapsed/refractory multiple myeloma. This study will also assess how safe the combination of pomalidomide, bortezomib and low dose dexamethasone is compared to the combination of bortezomib and low dose dexamethasone.

NCT ID: NCT01734785 Completed - Clinical trials for Diabetes Mellitus, Type 2

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Start date: January 2013
Phase: Phase 3
Study type: Interventional

This trial will compare the use of the FDC of empagliflozin and linagliptin to linagliptin alone as add-on to metformin in patients with T2DM.

NCT ID: NCT01732679 Completed - Cerebral Stroke Clinical Trials

Sunnaas International Network´s Stroke Study

SINs
Start date: September 2012
Phase: N/A
Study type: Observational

A descriptive study of the stroke rehabilitation content in specialized clinics in seven countries: procedures for admission to rehabilitation, services available and provided to patients, as well as duration of the stay and discharge routines. An observational study of changes in regard to the physical function, quality of life and psycho-social factors in stroke patients before and after specialized rehabilitation

NCT ID: NCT01730495 Terminated - Clinical trials for Chronic Fatigue Syndrome

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The hypothesis is that a subset of patients with chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME), including also patients with no clinical response after B-cell depletion therapy using the anti-CD20 antibody Rituximab, may benefit from tumor necrosis factor-alpha inhibition using Etanercept as weekly subcutaneous injections.